BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23264082)

  • 1. TAFI gene polymorphisms in patients with cerebral venous thrombosis.
    Tokgoz S; Zamani AG; Durakbasi-Dursun HG; Yilmaz O; Ilhan N; Demirel S; Tavli M; Sinan A
    Acta Neurol Belg; 2013 Sep; 113(3):291-7. PubMed ID: 23264082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplotypes of TAFI gene and the risk of cerebral venous thrombosis--a case-control study.
    Orikaza CM; Morelli VM; Matos MF; Lourenço DM
    Thromb Res; 2014 Jan; 133(1):120-4. PubMed ID: 24252537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation factor VII R353Q polymorphism and the risk of puerperal cerebral venous thrombosis.
    Kruthika-Vinod TP; Nagaraja D; Christopher R
    J Clin Neurosci; 2012 Jan; 19(1):190-1. PubMed ID: 22136731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of single nucleotide polymorphisms of the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI antigen levels in healthy children and pediatric oncology patients.
    Knoefler R; Ludwig K; Kostka H; Kuhlisch E; Siegert G; Suttorp M
    Semin Thromb Hemost; 2003 Dec; 29(6):575-83. PubMed ID: 14719174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems.
    Lichy C; Dong-Si T; Reuner K; Genius J; Rickmann H; Hampe T; Dolan T; Stoll F; Grau A
    J Neurol; 2006 Mar; 253(3):316-20. PubMed ID: 16155788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis.
    Qian K; Xu J; Wan H; Fu F; Lu J; Lin Z; Liu Z; Liu H
    Gene; 2015 Sep; 569(2):173-81. PubMed ID: 26071134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Polymorphisms Associated with Thrombotic Disease Comparison of Two Territories: Myocardial Infarction and Ischemic Stroke.
    Isordia-Salas I; Martínez-Marino M; Alberti-Minutti P; Ricardo-Moreno MT; Castro-Calvo R; Santiago-Germán D; Alvarado-Moreno JA; Calleja-Carreño C; Hernández-Juárez J; Leaños-Miranda A; Majluf-Cruz A
    Dis Markers; 2019; 2019():3745735. PubMed ID: 31781299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of polymorphisms in the 5'-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis.
    Franco RF; Fagundes MG; Meijers JC; Reitsma PH; Lourenço D; Morelli V; Maffei FH; Ferrari IC; Piccinato CE; Silva WA; Zago MA
    Haematologica; 2001 May; 86(5):510-7. PubMed ID: 11410415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the TAFI gene and the risk of venous thrombosis.
    Kostka H; Kuhlisch E; Schellong S; Siegert G
    Clin Lab; 2003; 49(11-12):645-7. PubMed ID: 14651335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
    Ben Salem-Berrabah O; Fekih-Mrissa N; N'siri B; Ben Hamida A; Benammar-Elgaaied A; Gritli N; Mrissa R
    J Clin Neurosci; 2012 Sep; 19(9):1326-7. PubMed ID: 22721898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation analysis of thrombin-activatable fibrinolysis inhibitor single nucleotide polymorphism with venous thromboembolism].
    Li C; Hou LH; Liu XE; Huang C; Wei XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):949-53. PubMed ID: 22931662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of methylenetetrahydrofolate reductase A1298C polymorphism in cerebral venous thrombosis.
    Fekih-Mrissa N; Klai S; Mrad M; Zaouali J; Sayeh A; Nsiri B; Gritli N; Mrissa R
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):118-9. PubMed ID: 23314385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XII C46T gene polymorphism and the risk of cerebral venous thrombosis.
    Reuner KH; Jenetzky E; Aleu A; Litfin F; Mellado P; Kloss M; Jüttler E; Grau AJ; Rickmann H; Patscheke H; Lichy C
    Neurology; 2008 Jan; 70(2):129-32. PubMed ID: 18180442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study.
    Sucker C; Hetzel GR; Farokhzad F; Dahhan F; Schmitz M; Kurschat C; Grabensee B; Maruhn-Debowski B; Zotz R; Scharf R
    Nephrol Dial Transplant; 2007 May; 22(5):1347-50. PubMed ID: 17327284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis.
    Martini CH; Brandts A; de Bruijne EL; van Hylckama Vlieg A; Leebeek FW; Lisman T; Rosendaal FR
    Br J Haematol; 2006 Jul; 134(1):92-4. PubMed ID: 16803573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine mapping of quantitative trait nucleotides underlying thrombin-activatable fibrinolysis inhibitor antigen levels by a transethnic study.
    Frère C; Tregouet DA; Morange PE; Saut N; Kouassi D; Juhan-Vague I; Tiret L; Alessi MC
    Blood; 2006 Sep; 108(5):1562-8. PubMed ID: 16705091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Denaturing high-performance liquid chromatography for screening antithrombin III gene mutation and polymorphisms in patients with cerebral venous thrombosis].
    Wang LP; Qiu YW; Yin AL; Ma YY; Liu KL; Xiong L; Yu YH; Zhong M; Wang C
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):1982-6. PubMed ID: 19861246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation DNA sequencing to identify novel genetic risk factors for cerebral vein thrombosis.
    Gorski MM; de Haan HG; Mancini I; Lotta LA; Bucciarelli P; Passamonti SM; Cairo A; Pappalardo E; van Hylckama Vlieg A; Martinelli I; Rosendaal FR; Peyvandi F
    Thromb Res; 2018 Sep; 169():76-81. PubMed ID: 30029070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
    Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy loss.
    Masini S; Ticconi C; Gravina P; Tomassini M; Pietropolli A; Forte V; Federici G; Piccione E; Bernardini S
    Fertil Steril; 2009 Aug; 92(2):694-702. PubMed ID: 18774564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.